Clinical Trial Update: WATCHMAN FLX™ CT Study [NA]

View source ↗

Summary

This clinical trial update reports the completion of the WATCHMAN FLX CT Study evaluating left atrial appendage closure to reduce stroke and life-threatening bl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• WATCHMAN FLX

Snippet

Sponsor: Boston Scientific Corporation | Conditions: The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2025-07-01